0 CHECKOUT

PRODUCT FILTERS

REGION

2,218
1,442
1,439
1,349
1,349

COUNTRY

1,334
147
89
87
86

CATEGORIES

  • 336
  • 322
  • 262
  • 248
  • 215
  • 196
  • 194
  • 159
  • 150
  • 145
  • 144
  • 134
  • 110
  • 104
  • 49

PRICE

616
1,203
2,203
4,919

PUBLISHED

247
468
2,617
4,919

PRODUCT TYPE

4,068
362
261
173
52
2
1

Oncology Drugs Market Research Reports

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

Global Cancer Monoclonal Antibodies Market & Pipeline Insight

Recent years have witnessed the emergence of monoclonal antibodies, which has the potential to offer less toxic and more efficient therapeutic alternatives for patients. Over the past decades, the researchers...

Published:  October 2014
Price:  From

Global Cancer Kinase Inhibitors Market & Pipeline Insight

The recent years have witnessed the emergence of kinase inhibitors, which have the potential to offer less toxic and more efficient therapeutic alternatives for patients. Over the past two decades,...

Published:  October 2014
Price:  From

Global Lung Cancer Vaccine Market & Pipeline Insight 2015

Lung cancer incidences are rapidly increasing and various therapeutics have been introduced in global market to provide better care to patients. Surgery and radiation therapy are not preferred for lung...

Published:  February 2015
Price:  From

Biomarker Technology Platforms for Cancer Diagnoses and Therapies 2014

Until superior therapeutic treatments are developed to prevent, treat and cure cancer, the best means of reducing mortality and morbidity in a disease this complex is early detection and diagnosis....

Published:  July 2014
Price:  From

Global Melanoma Therapeutics Market 2015-2019

About Melanoma According to Melanoma Research Foundation, melanoma is usually, but not always, a cancer of the skin. Melanoma is defined as a cancer that occurs in melanocytes (cells that make the...

Published:  April 2015
Price:  From

Global Multiple Myeloma Drugs Market 2015-2019

About Multiple Myeloma Multiple myeloma is a common cancer that affects the plasma cells, a type of white blood cell. It begins in the plasma cells of bone marrow. The primary function of the plasma...

Published:  December 2014
Price:  From

Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024

Antibody drug conjugates (ADCs) are a new class of therapeutic agents, gaining increasing attention from both large and small pharmaceutical companies. Generally addressed as the marriage of an antibody...

Published:  August 2014
Price:  From

Global Lung Cancer Therapeutics Market 2015-2019

About Lung Cancer Cancer occurs when, after undergoing cell transformation, normal cells grow and multiply without control. Lung cancer is a common cause of mortality and morbidity in both developed...

Published:  November 2014
Price:  From

Cancer Immunotherapy Market & Clinical Pipeline Insight

With more than 6 million deaths worldwide in 2013, cancer has become one of the most pressing health problems faced by almost all the economies of the world Inspite of the fact that there have been...

Published:  July 2014
Price:  From

Global Prostate Cancer Drugs Market 2014-2018

About Prostate Cancer Prostate cancer initiates in the prostate, which is an exocrine gland present in the male reproductive system. The main function of the prostate is to make fluid for semen. The...

Published:  November 2014
Price:  From

Global Oncology Biosimilars Market 2014-2018

About Oncology Biosimilars Biosimilars are follow-on versions of biological medicines that are developed after the expiry of the patent protection on the original product. Biosimilar medicines have...

Published:  November 2014
Price:  From

Global Acute Myeloid Leukemia Therapeutics Market 2015-2019

About Acute Myeloid Leukemia Acute myeloid leukemia, also known as acute myelogenous leukemia, is a hematopoietic disorder that starts either in hematopoietic stem cells or lineage-specific progenitor...

Published:  December 2014
Price:  From

Global Hodgkins Lymphoma Therapeutics Market 2014-2018

About Hodgkin's Lymphoma Hodgkin's Lymphoma (HL) is defined as the cancer of the lymph tissue, which is part of our immune system. The exact etiology of HL is unknown. However, the risk of developing...

Published:  August 2014
Price:  From

Global Non-small Cell Lung Cancer Market 2014-2018

About Non-small Cell Lung Cancer Non-small cell lung cancer occurs when normal cells grow and multiply without control after undergoing a cell transformation. Lung cancer is the leading cause of cancer...

Published:  September 2014
Price:  From

Global Pancreatic Cancer Market 2014-2018

About Pancreatic Cancer Pancreatic cancer is a malignant cells form in the tissues of pancreas. Based on the initiation, pancreatic cancer can be classified into exocrine pancreatic cancer and endocrine...

Published:  October 2014
Price:  From

Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market – Pipeline Forecast & Market Forecast in G8 Countries (2011 – 2020)

The acute lymphocytic/lymphoblastic leukemia therapeutics market has growth potential with increasing incidence rate of the disease across the globe The incidence of acute lymphocytic/lymphoblastic...

Published:  December 2013
Price:  From

Companion Diagnostics in Personalized Medicine and Cancer Therapy

Companion diagnostics (CDx) refers to a particular clinical diagnostic test that is under evaluation and is specifically linked to a known drug therapy. This linkage could be important in the therapeutic...

Published:  June 2014
Price:  From

Therapeutic Class Overview: Newer Oral Anti Androgens – Expanding Role in the Treatment Paradigm of Prostate Cancer

XTANDI (Enzalutamide) – Does it have potential to compete against ARN-509 in earlier setting? Zytiga (Abiraterone Acetate) – Ongoing Combination trials creates potential beyond Patent Expiry In recent...

Published:  February 2014
Price:  From

Global Orphan Cancer Drug Market & Clinical Pipeline Insight

The drug development strategies of the pharmaceutical companies is undergoing a paradigm shift from manufacturing traditional essential medicines to orphan drugs due to significant competition from...

Published:  June 2014
Price:  From

Cancer Cell Therapy Market & Pipeline Insight

Since the past 3-5 years, a more complex therapeutic modality has been is emerging as cell therapies which have been developed to treat diseases which are not amenable to treatment with more classical...

Published:  June 2014
Price:  From
Loading Indicator

Our Clients